Skip to main content
Clinical Trials/NCT02518399
NCT02518399
Completed
Not Applicable

Chronic Heat Therapy for Improving Biomarkers of Vascular Health in Young, Healthy, Humans

University of Oregon1 site in 1 country20 target enrollmentApril 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
University of Oregon
Enrollment
20
Locations
1
Primary Endpoint
Change in flow-mediated dilation
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of the study is to investigate whether long-term heat therapy (i.e. 8 weeks of hot tub 4-5x per week) improves biomarkers of cardiovascular health in young, healthy, able-bodied individuals. Although exercise is a potent means of improving cardiovascular health, many patients are unable to exercise effectively, and thus there is high demand for novel therapies to better manage cardiovascular risk in these patients. If successful, this study will set the groundwork for heat therapy to be used as an alternative treatment in patients who have limited exercise capabilities for the prevention of cardiovascular disease.

Detailed Description

Exercise training is a potent means of improving cardiovascular (CV) risk; however, exercise is challenging for many patient populations. Passive heat therapy may provide a simple and effective alternative to exercise for improving CV health, and no one has yet studied the physiological benefits of chronic heat exposure in humans. Heat exposure induces the expression of heat shock proteins, which can have a multitude of beneficial effects on the CV system, many of which are common to exercise training. In particular, these benefits include upregulation of many cellular pathways associated with improved vascular function, a predominant contributor to CV health. The goal of the study is to determine the effects of chronic passive heat therapy on vascular function in young, healthy, able-bodied individuals. The investigators will perform a randomized-controlled trial in which subjects participate in 8 weeks of either heat therapy or thermoneutral water immersion (sham). Heat therapy will entail 8 weeks of hot water immersion sufficient to raise core temperature \>38.5°C for 1h, 4-5 times per week. Thermoneutral water immersion will entail 8 weeks of immersion in 36°C water for the same duration as heat therapy. In both subject groups, the investigators will measure various well-established biomarkers of vascular function before and after 8 weeks of heat therapy, including measures of arterial stiffness (arterial compliance, beta-stiffness, and pulse wave velocity), endothelium-dependent dilation (flow-mediated dilation), and intima media thickness. The investigators will investigate the effects of heat therapy on the microvasculature and on the mechanisms behind improvements in vascular function in the cutaneous microcirculation, an ideal site for pharmacodissecting the molecular pathways involved, using microdialysis paired with laser-Doppler flowmetry. If successful, these studies will serve as a basis for developing heat therapy as a novel means of improving CV risk, which has the potential to reshape the treatment of patient populations with limited exercise capabilities.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
April 30, 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christopher T Minson, PhD

Professor

University of Oregon

Eligibility Criteria

Inclusion Criteria

  • Young, healthy, able-bodied

Exclusion Criteria

  • Diagnosis of any chronic diseases related to the cardiovascular system (e.g. hypertension, cardiovascular disease, diabetes, etc.),
  • Currently taking prescription medications (except contraceptives)
  • Body mass index over 27 kg/m2
  • Current smoking
  • Currently pregnant or breast-feeding

Outcomes

Primary Outcomes

Change in flow-mediated dilation

Time Frame: 8 weeks

The change in percent dilation of the brachial artery following release of a 5-min arterial occlusion, measured using ultrasonography. This test is highly prognostic of cardiovascular risk and mortality.

Femoral dynamic arterial compliance

Time Frame: 8 weeks

The change in compliance of the superficial femoral artery relative to blood pressure, measured using ultrasonography-tonometry. This is a measure of arterial stiffness.

Intima media thickness

Time Frame: 8 weeks

Change in wall thickness of the common carotid artery, measured using ultrasonography. This is predictive of future development of cardiovascular disease, in particular, atherosclerosis.

Mean arterial blood pressure

Time Frame: 8 weeks

Change in blood pressure measured using brachial oscillation following \>20 min supine rest.

Secondary Outcomes

  • Cutaneous nitric oxide-dependent dilation(8 weeks)

Study Sites (1)

Loading locations...

Similar Trials